“We feel honored to be part of such a reputable list of companies,” stated Dr. Todd R. Daviau, President and CEO of CoreRx. “From every single dosage form we develop to every minute we save our customers, we are always aiming to be the best company we can possibly be. Our commitment to our customers is reflected in our steady growth over the last five years.”
CoreRx is a contract research organization providing formulation development, preformulation, analytical, and clinical trial manufacturing to American and European companies since 2006. The company is renowned for reliably expediting early development activities to speed potential drugs to clinical trials while applying stage-specific scientific knowledge and experience. CoreRx’s unique corporate structure creates project teams that work intensively with each client, bringing an extension of their own organization into CoreRx.
As a fully cGMP contract facility, CoreRx provides formulation development, analytical, and clinical material resources, utilizing a variety of multi-layer tablet equipment for combination products. CoreRx also offers development and manufacture of multi-particulate combination drug products. Whether your need is for multiple tablets in a capsule, pellets, granules, nano-particles, co-processed spray dried powders or multiple powders in capsules, CoreRx has you covered.
Keep on top of new developments and throughout the drug development industry by following us on Twitter: www.twitter.com/CoreRx.